Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Avalo Therapeutics (AVTX) Receivables - Net (2016 - 2023)

Avalo Therapeutics filings provide 8 years of Receivables - Net readings, the most recent being $38000.0 for Q2 2023.

  • On a quarterly basis, Receivables - Net fell 93.01% to $38000.0 in Q2 2023 year-over-year; TTM through Jun 2023 was $38000.0, a 93.01% decrease, with the full-year FY2021 number at $1.1 million, down 51.31% from a year prior.
  • Receivables - Net hit $38000.0 in Q2 2023 for Avalo Therapeutics, down from $544000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $5.0 million in Q3 2019 to a low of $38000.0 in Q2 2023.
  • Median Receivables - Net over the past 5 years was $2.0 million (2020), compared with a mean of $2.1 million.
  • Biggest five-year swings in Receivables - Net: skyrocketed 117.34% in 2020 and later crashed 93.01% in 2023.
  • Avalo Therapeutics' Receivables - Net stood at $1.0 million in 2019, then surged by 117.34% to $2.2 million in 2020, then crashed by 51.31% to $1.1 million in 2021, then plummeted by 48.68% to $544000.0 in 2022, then crashed by 93.01% to $38000.0 in 2023.
  • The last three reported values for Receivables - Net were $38000.0 (Q2 2023), $544000.0 (Q2 2022), and $938000.0 (Q1 2022) per Business Quant data.